Loteprednol Etabonate And Tobramycin Solution/ Drops
Product Images NDC 82260-358

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate And Tobramycin (NDC 82260-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

The packaging label for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension 0.5%/0.3% by Bausch & Lomb. The label displays dosage strength, solution form, 10 mL volume, and sterile status. It includes storage instructions, dosage information, barcodes, and warnings such as "Keep Out of Reach of Children" and "Shake Vigorously Before Using." The label also notes prescription use only.*

FDA Label Image

Chemstructure1 (Image 01)

Chemical structure of loteprednol etabonate showing its molecular formula C24H31ClO7 and molecular weight 466.96.*

FDA Label Image

Image2 (Image 02)

Chemical structure of the active ingredient loteprednol etabonate and tobramycin, depicted with its molecular formula C18H37N5O9 and molecular weight 467.52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.